SLC27A3 and glioma: Activation of both oncogenic receptor tyrosine kinases (RTK) c-Met and EGFR contributes to increased ACSVL3 levels in glioma cells, whereas silencing ACSVL3 leads to de-activation of Akt signaling [189].